|
AU2013276963A1
|
|
Pharmaceutical compositions for sublingual delivery of opioids
|
|
GB201317023D0
|
|
Medicament delivery device
|
|
GB201204769D0
|
|
COC containers and delivery devices for the sublingual administration of opioids
|
|
GB201122041D0
|
|
Drug delivery technology
|
|
GB201121693D0
|
|
Medicament delivery technology
|
|
GB201121503D0
|
|
Statin formulations for transmucosal delivery
|
|
GB201112743D0
|
|
Formulations and delivery devices for the sublingual administration of opioids
|
|
GB201006818D0
|
|
Composition for use in the sublingual delivery of medicaments to humans
|
|
AU2010240653A1
|
|
Sublingual pharmaceutical composition comprising a neutral oil
|
|
ME02008B
|
|
Sublingual spray formulation comprising dihydroartemesinin
|
|
WO2010122276A1
|
|
Drug delivery
|
|
GB201115179D0
|
|
Transmucosal formulation of compounds providing dihydroartemesinin for use in the treatment of Lyme disease
|
|
WO2010122275A1
|
|
Pharmaceutical preparation
|
|
GB0906971D0
|
|
Transmucosal formulation of compounds providing dihydroartemesinin for use in the treatment of neoplastic disease
|
|
GB201115173D0
|
|
Transmucosal formulation of compounds providing dihydroartemesinin for use in the treatment of fluke infestation
|
